Directory
>
Mohamed Genead Md
Mohamed Genead Md
Co-Founder & CEO | Aviceda Therapeutics
Cambridge, Massachusetts, United States
Mohamed Genead Md
Summary
Mohamed Genead Md is a visionary leader in the biotechnology sector, serving as the Co-Founder, CEO, and President of Aviceda Therapeutics. With a robust background as a retina specialist, he has dedicated over 15 years to pioneering innovative therapies aimed at curing blindness through advanced glyco-biology and gene therapy. His entrepreneurial journey is marked by successful ventures, substantial revenue generation exceeding $1 billion, and strategic partnerships with major pharmaceutical companies. Mohamed's expertise spans clinical development, regulatory compliance, and global drug development, making him a trusted advisor in the biotech ecosystem. He is passionate about leveraging technology to improve patient outcomes and has been instrumental in facilitating significant funding rounds for emerging biotech firms. His commitment to research is evident in his extensive publication record and ongoing contributions to the field of ophthalmology.
Mohamed Genead Md
Work Experience
Co-Founder & CEO at
Aviceda Therapeutics
February 2023 - Present
Co-Founder, CEO & President, Executive Board Director at
Aviceda Therapeutics
May 2018 - Present
Principal & Founder at
Ophelia Bioconsulting LLC
January 2018 - Present
GLG Council Member at
GERSON LEHRMAN GROUP (AUSTRALIA) PTY LTD
January 2015 - Present
Strategic Corporate & Business Advisor Small/Med Cap Biotech at
Ophelia Bioconsulting LLC
April 2013 - Present
Chair Scientific Advisory Board at
Ocugen
February 2019 - July 2021
Scientific Advisor at
Atlas Venture
January 2017 - January 2019
Chief Medical Officer | Executive Vice-President at
GenSight Biologics
April 2017 - August 2018
Senior Medical Director, Ophthalmology/Retina Gene Therapy at
Biogen
January 2016 - January 2017
Global Executive Medical Director, Head of Ophthalmology/Retina Therapeutic Area at
Allegro Ophthalmics, LLC
January 2015 - May 2016
Global Medical Director | Ophthalmology | Retina Therapeutic Area at
AbbVie
January 2012 - January 2015
Ophthalmologist | Retina Specialist at
The University of Illinois At Chicago
January 2008 - January 2012
Mohamed Genead Md
Education
University of Illinois at Chicago, Medical Retina Fellowship | Ophthalmologist | Retina Specialist
January 2008 - January 2009
Medical College of Wisconsin, Retina Reseach Fellowship
January 2004 - January 2008
Suez Canal University, Ophthalmology Surgical & Medical Residency
January 2001 - January 2004
Suez Canal University, Doctor Of Medicine - Md
January 1993 - January 2001
Frequently Asked Questions about Mohamed Genead Md
What is Mohamed Genead Md email address?
Mohamed Genead Md's primary email address is **************@xenonarc.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mohamed Genead Md work for?
Mohamed Genead Md is a Co-Founder & CEO at Aviceda Therapeutics, a company specializing in Commercial physical research.
Where Mohamed Genead Md graduated from?
Mohamed Genead Md holds a degree in Retina & Herediatry Retinal Degeneration from University of Illinois at Chicago.
How can I directly contact Mohamed Genead Md?
To contact Mohamed Genead Md directly, you can use the email address **************@xenonarc.com. Complete contact information is available upon registration with Muraena.
Who is Mohamed Genead Md?
Mohamed Genead Md is a visionary leader in the biotechnology sector, serving as the Co-Founder, CEO, and President of Aviceda Therapeutics. With a robust background as a retina specialist, he has dedicated over 15 years to pioneering innovative therapies aimed at curing blindness through advanced glyco-biology and gene therapy. His entrepreneurial journey is marked by successful ventures, substantial revenue generation exceeding $1 billion, and strategic partnerships with major pharmaceutical companies. Mohamed's expertise spans clinical development, regulatory compliance, and global drug development, making him a trusted advisor in the biotech ecosystem. He is passionate about leveraging technology to improve patient outcomes and has been instrumental in facilitating significant funding rounds for emerging biotech firms. His commitment to research is evident in his extensive publication record and ongoing contributions to the field of ophthalmology.
Mohamed`s contact details
**************@xenonarc.com
**************@glg.it
*******@avicedarx.com
*******@palleonpharma.com
Colleagues
Executive Director-Research
Clinical Associate Professor
General Manager
Chief Medical Officer